Catalano A - Search Results

1

Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments.

Catalano A, Gianni W, Procopio A. Catalano A, et al. Crit Rev Oncol Hematol. 2004 May;50(2):101-9. doi: 10.1016/j.critrevonc.2003.10.001. Crit Rev Oncol Hematol. 2004. PMID: 15157659 Review.

2

Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention.

Catalano A, Graciotti L, Rinaldi L, Raffaelli G, Rodilossi S, Betta P, Gianni W, Amoroso S, Procopio A. Catalano A, et al. Int J Cancer. 2004 Apr 10;109(3):322-8. doi: 10.1002/ijc.11710. Int J Cancer. 2004. PMID: 14961568

3

Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen.

Catalano A, Romano M, Martinotti S, Procopio A. Catalano A, et al. Oncogene. 2002 Apr 25;21(18):2896-900. doi: 10.1038/sj.onc.1205382. Oncogene. 2002. PMID: 11973650

4

Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells.

Catalano A, Rodilossi S, Rippo MR, Caprari P, Procopio A. Catalano A, et al. J Biol Chem. 2004 Nov 5;279(45):46706-14. doi: 10.1074/jbc.M406696200. Epub 2004 Aug 26. J Biol Chem. 2004. PMID: 15337769 Free article.

5

5-lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking.

Catalano A, Caprari P, Soddu S, Procopio A, Romano M. Catalano A, et al. FASEB J. 2004 Nov;18(14):1740-2. doi: 10.1096/fj.04-2258fje. Epub 2004 Sep 16. FASEB J. 2004. Retraction in: FASEB J. 2024 Jun 15;38(11):e23686. doi: 10.1096/fsb2.23686 PMID: 15375079 Retracted.

6

Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma.

Lazzarini R, Moretti S, Orecchia S, Betta PG, Procopio A, Catalano A. Lazzarini R, et al. Among authors: catalano a. Clin Cancer Res. 2008 Aug 15;14(16):5099-107. doi: 10.1158/1078-0432.CCR-08-0255. Clin Cancer Res. 2008. PMID: 18698027

7

The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells.

Catalano A, Lazzarini R, Di Nuzzo S, Orciari S, Procopio A. Catalano A, et al. Cancer Res. 2009 Feb 15;69(4):1485-93. doi: 10.1158/0008-5472.CAN-08-3659. Epub 2009 Jan 27. Cancer Res. 2009. PMID: 19176370

8

Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity.

Catalano A, Romano M, Robuffo I, Strizzi L, Procopio A. Catalano A, et al. Am J Pathol. 2001 Aug;159(2):721-31. doi: 10.1016/S0002-9440(10)61743-9. Am J Pathol. 2001. PMID: 11485930 Free PMC article.

9

New aspects on the role of lipoxygenases in cancer progression.

Catalano A, Procopio A. Catalano A, et al. Histol Histopathol. 2005 Jul;20(3):969-75. doi: 10.14670/HH-20.969. Histol Histopathol. 2005. PMID: 15944947 Review.

10

FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells.

Rippo MR, Moretti S, Vescovi S, Tomasetti M, Orecchia S, Amici G, Catalano A, Procopio A. Rippo MR, et al. Among authors: catalano a. Oncogene. 2004 Oct 14;23(47):7753-60. doi: 10.1038/sj.onc.1208051. Oncogene. 2004. PMID: 15334061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters